Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

LLY

Lilly(Eli) & Co

Jun 13 • 04:00PM ET

819.36

Dollar change 0.00
Percentage change 0.00	%

Healthcare • Drug Manufacturers - General • USA • NYSE

Peers: NVO JNJ ABBV MRK AZN AMGN PFE SNY BMY GSK

| Held by: VTI VOO SPY IVV VUG XLV VIG IWF QUAL VHT

Scroll to Statements

Index	S&P 500	P/E	67.88	EPS (ttm)	12.07	Insider Own	10.35%	Shs Outstand	948.10M	Perf Week	6.43%
Market Cap	776.54B	Forward P/E	27.64	EPS next Y	29.65	Insider Trans	-0.89%	Shs Float	849.66M	Perf Month	14.51%
Income	11.11B	PEG	1.64	EPS next Q	5.56	Inst Own	73.61%	Short Float	0.94%	Perf Quarter	0.72%
Sales	49.00B	P/S	15.85	EPS this Y	67.82%	Inst Trans	0.80%	Short Ratio	1.98	Perf Half Y	2.47%
Book/sh	16.63	P/B	49.28	EPS next Y	36.01%	ROA	14.49%	Short Interest	8.03M	Perf Year	-5.37%
Cash/sh	3.40	P/C	241.11	EPS next 5Y	41.42%	ROE	77.73%	52W Range	677.09 - 972.53	Perf YTD	6.13%
Dividend Est.	6.57 (0.80%)	P/FCF	207.82	EPS past 5Y	18.77%	ROIC	22.10%	52W High	-15.75%	Beta	0.39
Dividend TTM	5.60 (0.68%)	Quick Ratio	1.06	Sales past 5Y	15.08%	Gross Margin	81.70%	52W Low	21.01%	ATR (14)	21.32
Dividend Ex-Date	May 16, 2025	Current Ratio	1.37	EPS Y/Y TTM	80.73%	Oper. Margin	40.25%	RSI (14)	64.93	Volatility	1.89% 1.61%
Employees	47000	Debt/Eq	2.44	Sales Y/Y TTM	36.38%	Profit Margin	22.66%	Recom	1.52	Target Price	987.22
Option/Short	Yes / Yes	LT Debt/Eq	2.19	EPS Q/Q	23.46%	Payout	44.39%	Rel Volume	0.00	Prev Close	819.36
Sales Surprise	0.48%	EPS Surprise	2.51%	Sales Q/Q	45.17%	Earnings	May 01 BMO	Avg Volume	4.06M	Price	819.36
SMA20	8.25%	SMA50	5.81%	SMA200	-0.91%	Trades		Volume	0	Change	0.00%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-05-25	Downgrade	Erste Group	Buy → Hold
Apr-28-25	Downgrade	HSBC Securities	Buy → Reduce	$1150 → $700
Apr-22-25	Initiated	Cantor Fitzgerald	Overweight	$975
Dec-10-24	Resumed	BofA Securities	Buy	$997
Nov-15-24	Initiated	Wolfe Research	Outperform	$1000
Oct-17-24	Initiated	Bernstein	Outperform	$1100
Sep-13-24	Resumed	Citigroup	Buy	$1060
Aug-12-24	Upgrade	Deutsche Bank	Hold → Buy	$1025
Feb-21-24	Downgrade	DZ Bank	Buy → Hold	$820
Feb-16-24	Reiterated	Morgan Stanley	Overweight	$805 → $950
Dec-21-23	Downgrade	Daiwa Securities	Buy → Outperform	$660 → $610
Nov-09-23	Initiated	Deutsche Bank	Hold	$535
Oct-20-23	Resumed	UBS	Buy	$612 → $710
Aug-09-23	Upgrade	Jefferies	Hold → Buy	$408 → $615
Jul-26-23	Reiterated	Citigroup	Buy	$360 → $525
Jul-14-23	Initiated	HSBC Securities	Buy	$560
May-24-23	Reiterated	UBS	Buy	$447 → $498
May-24-23	Reiterated	BofA Securities	Buy	$450 → $500
Mar-13-23	Upgrade	Wells Fargo	Equal Weight → Overweight	$360 → $375
Mar-06-23	Initiated	Jefferies	Hold	$290

Show Previous Ratings

Today 07:45AM	The Zacks Analyst Blog Highlights Eli Lilly, Home Depot, SAP and Natural Resource Partners (Zacks)
07:04AM	3 Growth Stocks You Can Buy Right Now Without Any Hesitation (Motley Fool)
06:45AM	Lilly to offer all approved doses of Zepbound (tirzepatide) single-dose vials through LillyDirect Self Pay Pharmacy Solutions (PR Newswire)
Jun-15-25 10:00AM	Pharma manufacturing 'boom' faces high costs, potential delays (Yahoo Finance)
07:30AM	Eli Lilly Just Made Another Move to Dominate the Weight Loss Market: Should You Buy the Stock? (Motley Fool)
05:46AM	Loading…
05:46AM	Goldman Sachs Remains a Buy on Eli Lilly (LLY) With an $883 Price Target (Insider Monkey)
05:22AM	Jim Cramer on Eli Lilly: "We Like It" (Insider Monkey)
Jun-14-25 04:40AM	1 Growth Stock Down 9% to Buy Right Now (Motley Fool)
Jun-13-25 04:31PM	Top Analyst Reports for Eli Lilly, Home Depot & SAP (Zacks)
12:58PM	Novo Nordisk Is Europe's Most Valuable Company-Again. Eli Lilly, Watch Out. (Barrons.com)
12:45PM	Senators to propose ban on drug ads to consumers, WSJ reports (TipRanks)
10:41AM	Lilly Moves Past 50-Day Average: Should You Buy the Stock Now? (Zacks)
10:00AM	Tariffs Create Most Patriotic Earnings Season Yet as US Firms Pander to Trump (Bloomberg)
09:08AM	NVO Stock up on Plans to Advance Obesity Candidate Amycretin (Zacks)
03:10AM	Down 12%, Should You Buy the Dip on Eli Lilly? (Motley Fool)
02:12PM	Loading…
Jun-12-25 02:12PM	Abbott Laboratories Stock Sees RS Rating Rise To 82 (Investor's Business Daily)
Jun-11-25 10:57AM	Trump Wants Cheaper Drugs Like Europe Has. How It Works. (Barrons.com)
10:20AM	Trump Trade: RFK Jr. removes members of vaccine-advising CDC panel (TipRanks)
10:00AM	NVO Stock Gains After Parvus Asset Management Builds Stake (Zacks)
09:38AM	Can Mounjaro, Zepbound Help Lilly Maintain Dominance in Obesity Space? (Zacks)
09:32AM	Eli Lilly telehealth partners continue to sell compounded GLP-1 weight-loss drugs despite agreement not to (Yahoo Finance)
06:20AM	Should You Invest in the Health Care Select Sector SPDR ETF (XLV)? (Zacks)
06:20AM	Should You Invest in the iShares U.S. Healthcare ETF (IYH)? (Zacks)
04:23AM	Should You Buy Eli Lilly Stock Before June 22? (Motley Fool)
03:13AM	The cheap fat jabs sending big pharma into a frenzy (The Telegraph)
Jun-10-25 04:27PM	Eli Lilly telehealth deals to prevent sale of compounded GLP-1s (Yahoo Finance Video)
03:35PM	Hims & Hers stock falls after Lilly rules out partnership (Investing.com)
02:03PM	Drug pricing reform talks with US government lack clarity, industry executives say (Reuters)
01:56PM	Energy and healthcare stocks power S&P 500 higher (MarketWatch)
11:10AM	Novo Nordisk Stock Climbs on Report of Activist Investor Parvus Building Stake (Investopedia)
10:23AM	Loading…
10:23AM	Top Cancer Stocks to Supercharge Your 2025 Portfolio (Zacks)
09:02AM	Have Skyrizi and Rinvoq Successfully Saved AbbVie From Humira LoE? (Zacks)
08:27AM	Weight-Loss Drugs Pose Long-Term Threat To McDonald's: Analyst (Investor's Business Daily)
08:27AM	McDonald's Stock Bitten By Big Downgrade Over Weight-Loss Drugs (Investor's Business Daily)
08:19AM	Scorpion, fresh off Lilly deal, spins out startup Antares (BioPharma Dive)
03:33AM	2 Weight Loss Drug Stocks That Are Screaming Buys in June (Motley Fool)
Jun-09-25 08:59PM	Eli Lilly Bets $870 Million on Extended-Release Obesity Drugs (GuruFocus.com)
04:08PM	Obesity Newcomer Metsera Enters The Ring With A Punch And A Big Stock Jump (Investor's Business Daily)
12:05PM	Eli Lilly and Company (LLY): A Bull Case Theory (Insider Monkey)
10:18AM	Pfizer Stock Down Almost 11% YTD: Should You Buy the Dip? (Zacks)
09:43AM	Obesity Newcomer Metsera, Up 23%, Enters The Ring With A Punch (Investor's Business Daily)
09:00AM	Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
08:11AM	Eli Lilly's Obesity Drug Success Spurs Japanese Biotech's Anti-Muscle-Wasting Combo Therapy (Benzinga)
04:25AM	5 Monster Stocks to Hold for the Next 10 Years (Motley Fool)
04:00AM	The biggest obesity deals of 2025 so far (Pharma Voice)
Jun-07-25 06:10PM	Billionaire Stanley Druckenmiller Has Unloaded Shares of Last Year's 2 Top Performing AI Stocks and Is Piling Into a Growth Stock That Has Climbed 150% in 3 Years (Motley Fool)
08:44AM	With Novo Nordisk's CEO Out, Wall Street Wants an American Leader (MarketBeat)
Jun-06-25 08:20PM	Analyst Report: Eli Lilly and Company (Morningstar Research)
04:16PM	Challenges pharma companies face in push into US manufacturing (Yahoo Finance Video)
04:08PM	Healthcare companies are hiring. Is it time to look for growth stocks in this beaten-down sector? (MarketWatch)
04:06PM	The Next Look At Amgen's Obesity Drug Is Coming. Here's What Investors Are Watching. (Investor's Business Daily)
12:38PM	Is Novo Nordisk's Next Generation Obesity Pipeline a Game Changer? (Zacks)
09:40AM	Salesforce initiated, Dollar Tree upgraded: Wall Streets top analyst calls (TipRanks)
06:38AM	Rare Outflow Signals Hit Eli Lilly Shares (FX Empire)
04:40AM	Novo Nordisk Stock: Is It Still a Smart Buy? (Motley Fool)
01:30AM	Despite Trade War, U.S. Drug Companies Turn to China for Key Cancer Treatments (Barrons.com)
Jun-05-25 09:15PM	Eli Lilly (LLY)'s Target Price Slashed to $960 by TD Cowen, Reiterates Buy Rating (Insider Monkey)
01:48PM	Agency warns that weight-loss drugs can decrease effectiveness of birth control pills (Fortune)
09:22AM	Time to Buy These 3 Cheap Stocks? (Motley Fool)
09:10AM	Pre-Tariff Pharma Stockpiling Gives Irish Economy a Huge Shot in the Arm (The Wall Street Journal)
09:10AM	Pre-Tariff Pharma Stockpiling Gives Irish Economy a Huge Booster Shot (The Wall Street Journal)
08:45AM	REGN Strengthens Obesity Pipeline: Will the Move Revive the Stock? (Zacks)
04:15AM	Should You Invest $1,000 in Eli Lilly today? (Motley Fool)
Jun-04-25 02:08PM	These 7 Stocks Are Analyst Favorites For Magnificent Earnings Growth; Broadcom Results Ahead (Investor's Business Daily)
08:08AM	Camurus and Eli Lilly collaborate on long-acting incretin products (Pharmaceutical Business Review)
07:01AM	Lilly partners with Camurus in search of a long-lasting obesity drug (BioPharma Dive)
06:15AM	1 Underrated Reason to Buy This Market-Beating Stock (Motley Fool)
05:12AM	Prediction: Eli Lilly Will Reach a $1 Trillion Valuation by 2027 (Motley Fool)
Jun-03-25 06:20AM	Should You Invest in the Vanguard Health Care ETF (VHT)? (Zacks)
Jun-02-25 10:00AM	Lilly to participate in Goldman Sachs 46th Annual Global Health Care Conference (PR Newswire)
08:00AM	Lilly presents first clinical data for its investigational, next-generation FR targeting ADC in platinum-resistant ovarian cancer at the 2025 ASCO Annual Meeting (PR Newswire)
07:44AM	Kymera Stock Jumps 41%. New Dermatitis Pill Could Challenge Regeneron Blockbuster. (Barrons.com)
07:12AM	Weight Loss Drug ETF (THNR) Hits New 52-Week High (Zacks)
06:45AM	Could Viking Therapeutics Become the Next Eli Lilly? (Motley Fool)
May-30-25 05:28PM	Why the S&P 500 and Nasdaq Just Had Their Best Month Since 2023 (Investopedia)
10:00AM	Pharma Stock Roundup: LLY's New Deal, GSK & SNY's Pipeline Updates (Zacks)
07:30AM	3 American Growth Giants to Invest in for the Long Haul (Motley Fool)
05:00AM	How Ozempic maker Novo Nordisk fell behind Eli Lilly in the weight loss drug race (Quartz)
May-29-25 05:00PM	Lilly announces details of presentations at American Diabetes Association's (ADA) 85th Scientific Sessions (PR Newswire)
04:43PM	Was Jim Cramer Right About Eli Lilly and Company (LLY)? (Insider Monkey)
03:35PM	Heart Disease Could Be a Goner When These New Drugs Arrive (Barrons.com)
11:40AM	PFE or LLY: Which Is the Better Value Stock Right Now? (Zacks)
10:30AM	Novo Nordisk Is Shedding Muscle In The Weight-Loss Brawl With Eli Lilly (Investor's Business Daily)
09:31AM	AbbVie Stock Down Around 13% in 3 Months: Time to Buy the Dip? (Zacks)
07:35AM	Eli Lilly : A Breakout Biotech Powerhouse With Room to Run (MarketBeat)
May-28-25 09:00PM	How Ozempics Maker Lost Its Grip on the Obesity Market It Created (The Wall Street Journal)
11:27AM	Eli Lilly to Expand Pain Pipeline With $1B SiteOne Buyout Offer (Zacks)
09:22AM	Eli Lilly vs. AstraZeneca: Which Pharma Powerhouse is the Better Buy? (Zacks)
May-27-25 05:54PM	Jim Cramer Notes Eli Lilly (LLY) Stock is at a "Decent Level to Start a Position" (Insider Monkey)
03:25PM	Eli Lilly Targets Pain Management Opportunity with SiteOne Therapeutics Acquisition (Insider Monkey)
01:25PM	Eli Lilly to expand pain pipeline with $1bn SiteOne buyout (Pharmaceutical Technology)
12:38PM	Novo Nordisk vs. Viking Therapeutics: Which GLP-1 Stock Has More Upside? (Zacks)
10:59AM	Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics (Investing.com)
10:36AM	Why Novo Nordisk Stock Just Popped (Motley Fool)
10:00AM	Whats the Price Outlook for Weight-Loss Drugs? (The Wall Street Journal)
10:00AM	RXRX vs. SDGR: Which AI-Powered Drug Discovery Stock Has More Upside? (Zacks)
10:00AM	Lilly to expand its pain pipeline with acquisition of SiteOne Therapeutics (PR Newswire)
09:00AM	Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know (Zacks)
08:30AM	Lilly to buy pain drug developer SiteOne, challenging Vertex (BioPharma Dive)
04:44AM	Here's How the Pharmaceutical Import Tariffs Could Affect Eli Lilly (Motley Fool)

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Zakrowski Donald A	SVP, Finance, & CAO	May 27 '25	Sale	716.41	1,000	716,410	4,840	May 27 04:13 PM
Yuffa Ilya	EVP & President, LLY Int'l	May 14 '25	Sale	749.24	1,250	936,550	27,510	May 15 04:17 PM
Yuffa Ilya	Officer	May 14 '25	Proposed Sale	749.24	2,500	1,873,100		May 14 12:25 PM
DONALD ZAKROWSKI	Officer	Mar 13 '25	Proposed Sale	821.86	2,000	1,643,720		Mar 13 04:57 PM
Zakrowski Donald A	SVP, Finance, & CAO	Mar 13 '25	Sale	818.24	1,000	818,240	5,840	Mar 13 04:17 PM
LILLY ENDOWMENT INC	10% Owner	Mar 03 '25	Sale	928.76	220,000	204,326,151	96,016,978	Mar 04 04:00 PM
Dozier Eric	EVP, Chief People Officer	Mar 01 '25	Option Exercise	0.00	2,403	0	10,905	Mar 03 04:53 PM
Hernandez Edgardo	EVP & Pres., Mfg. Operations	Mar 01 '25	Option Exercise	0.00	2,837	0	41,009	Mar 03 04:51 PM
LILLY ENDOWMENT INC	10% Owner	Mar 03 '25	Proposed Sale	920.63	220,000	202,538,600		Mar 03 03:34 PM
LILLY ENDOWMENT INC	10% Owner	Feb 25 '25	Sale	903.07	225,000	203,190,794	96,236,978	Feb 26 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 24 '25	Sale	883.97	60,432	53,419,955	96,461,978	Feb 25 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 25 '25	Proposed Sale	881.40	225,000	198,315,000		Feb 25 03:05 PM
LILLY ENDOWMENT INC	10% Owner	Feb 21 '25	Sale	882.70	99,452	87,786,505	96,522,410	Feb 24 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 20 '25	Sale	877.99	14,685	12,893,353	96,621,862	Feb 21 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 19 '25	Sale	878.45	9,985	8,771,285	96,636,547	Feb 20 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 13 '25	Sale	879.52	35,446	31,175,396	96,646,532	Feb 14 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 13 '25	Proposed Sale	872.97	220,000	192,053,400		Feb 13 03:43 PM
Skovronsky Daniel	EVP, CSO & Pres. LRL & LLY Imm	Feb 10 '25	Sale	863.21	5,000	4,316,065	117,888	Feb 12 04:15 PM
Skovronsky Daniel	Officer	Feb 10 '25	Proposed Sale	863.19	5,000	4,315,954		Feb 10 11:44 AM
LILLY ENDOWMENT INC	10% Owner	Feb 06 '25	Sale	874.13	210,000	183,567,262	96,681,978	Feb 07 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 06 '25	Proposed Sale	842.18	210,000	176,857,800		Feb 06 04:04 PM
Yuffa Ilya	EVP & President, LLY Int'l	Feb 01 '25	Option Exercise	0.00	3,269	0	23,071	Feb 04 04:28 PM
White Anne E.	EVP & Pres, Lilly Neuroscience	Feb 01 '25	Option Exercise	0.00	3,269	0	68,838	Feb 04 04:27 PM
Van Naarden Jacob	EVP & Pres., Lilly Oncology	Feb 01 '25	Option Exercise	0.00	3,023	0	14,868	Feb 04 04:26 PM
Skovronsky Daniel	EVP, CSO & Pres. LRL & LLY Imm	Feb 01 '25	Option Exercise	0.00	8,989	0	126,892	Feb 04 04:25 PM
Ricks David A	President, Chair, and CEO	Feb 01 '25	Option Exercise	0.00	26,561	0	496,385	Feb 04 04:24 PM
Rau Diogo	EVP & CIDO	Feb 01 '25	Option Exercise	0.00	3,269	0	14,370	Feb 04 04:23 PM
Jonsson Patrik	EVP&Pres, CardMetHlth, LLY USA	Feb 01 '25	Option Exercise	0.00	3,433	0	48,016	Feb 04 04:23 PM
Hernandez Edgardo	EVP & Pres., Mfg. Operations	Feb 01 '25	Option Exercise	0.00	2,861	0	33,479	Feb 04 04:21 PM
Hakim Anat	EVP, GC & Secretary	Feb 01 '25	Option Exercise	0.00	4,904	0	20,683	Feb 04 04:19 PM
Zakrowski Donald A	Officer	Nov 08 '24	Proposed Sale	803.38	900	723,042		Nov 08 04:54 PM
Zakrowski Donald A	SVP, Finance, & CAO	Nov 08 '24	Sale	803.38	900	723,042	5,480	Nov 08 04:18 PM
Montarce Lucas	EVP & CFO	Nov 01 '24	Option Exercise	0.00	1,074	0	11,541	Nov 05 04:15 PM
Hernandez Edgardo	EVP & Pres., Mfg. Operations	Nov 01 '24	Option Exercise	0.00	1,687	0	31,369	Nov 05 04:14 PM
Dozier Eric	EVP, HR & Diversity	Nov 01 '24	Option Exercise	0.00	1,534	0	8,724	Nov 05 04:13 PM
LILLY ENDOWMENT INC	10% Owner	Sep 03 '24	Sale	966.69	24,084	23,281,840	96,891,978	Sep 04 04:05 PM
LILLY ENDOWMENT INC	10% Owner	Aug 27 '24	Sale	968.46	24,552	23,777,668	96,916,062	Aug 28 04:05 PM
Zakrowski Donald A	Officer	Aug 26 '24	Proposed Sale	950.00	750	712,500		Aug 26 04:47 PM
Zakrowski Donald A	SVP, Finance, & CAO	Aug 26 '24	Sale	950.00	750	712,500	6,380	Aug 26 04:21 PM
LILLY ENDOWMENT INC	10% Owner	Aug 22 '24	Sale	966.33	3,196	3,088,382	96,940,614	Aug 23 04:05 PM
LILLY ENDOWMENT INC	10% Owner	Aug 22 '24	Proposed Sale	951.97	215,000	204,673,550		Aug 22 12:54 PM
LILLY ENDOWMENT INC	10% Owner	Jul 10 '24	Sale	939.82	210,000	197,361,398	96,943,810	Jul 11 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jul 08 '24	Sale	918.64	93,593	85,977,954	97,153,810	Jul 09 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jul 05 '24	Sale	915.18	52,369	47,927,194	97,247,403	Jul 08 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jul 03 '24	Sale	915.31	8,848	8,098,655	97,299,772	Jul 03 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jul 01 '24	Sale	915.26	58,749	53,770,776	97,308,620	Jul 02 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 28 '24	Sale	915.02	1,441	1,318,545	97,367,369	Jul 01 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 25 '24	Sale	903.82	188,100	170,009,262	97,368,810	Jun 26 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 24 '24	Sale	902.38	17,229	15,547,068	97,556,910	Jun 25 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 20 '24	Sale	902.67	9,671	8,729,733	97,574,139	Jun 21 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 17 '24	Sale	885.91	194,978	172,733,708	97,583,810	Jun 18 04:00 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

LLY

Lilly(Eli) & Co

Upgrade your FINVIZ experience